PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 13 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Extract of dried fruit pulp showed protective potential against DSS-induced ulcerative colitis in male BALB/c mice [PMID:39490247]
Kadukkai maathirai (KM) prevented cancer progression in DEN-induced HCC in rats by increasing GSTM1 [PMID:39916986]
Isolated compounds from T. chebula var. tomentella exhibited anti-inflammatory activities, with some showing strong NO inhibitory activity [PMID:32209392, PMID:33892063]
Evidence summary
PubMed sources
- 1.PMID: 24909016 (2014) — Unique aspect of Tibetan medicine. · Acupuncture & electro-therapeutics research
- 2.PMID: 24501534 (2013) — Haritaki (Chebulic myrobalan) and its varieties. · Ayu
- 3.PMID: 36679584 (2023) — Natural Nitrogen-Doped Carbon Dots Obtained from Hydrothermal Carbonization of Chebulic Myrobalan and Their Sensing Ability toward Heavy Metal Ions. · Sensors (Basel, Switzerland)
- 4.PMID: 39490247 (2024) — Coloprotective effects of chebulic myrobalan extract by regulation of AMPK-SIRT1 signaling: A pharmacological and histopathological evaluation. · Tissue & cell
- 5.PMID: 33892063 (2021) — Multiple in vitro biological effects of phenolic compounds from Terminalia chebula var. tomentella.